月見草油 Evening Primrose Oil × 皮膚健康
結論：主流反證據
口服月見草油用於皮膚健康（特別是異位性濕疹）擁有極強且一致的反證據鏈：2013 Cochrane SR（19 RCT, n=1596）受試者自評 SMD -0.
U ⚫ U 未驗證 主流反證據 🚨 high — heavy affiliate marketing in TW community
口服月見草油用於皮膚健康（特別是異位性濕疹）擁有極強且一致的反證據鏈：2013 Cochrane SR（19 RCT, n=1596）受試者自評 SMD -0.02 (95% CI -0.24~0.20) 明確無效並建議停止此方向研究；2014 AAD CPG 明文不推薦；NCCIH/Mayo/Cleveland Clinic 皆否定其皮膚效益；NHS/MHRA 於 2002 撤銷 Epogam 藥證；EFSA 全數駁回 GLA 與皮膚屏障/結構之健康宣稱；FDA 對標榜濕疹/牛皮癬之 EPO 產品發警告函。
L1 Examine grade D（n=7, 176, No effect）與多源高品質證據完全一致。
少數陽性訊號（2014 韓國 n=50, EASI -1.0, p=0.04）為短期低劑量小樣本低品質試驗，無法翻轉主流結論。
屬典型 D（反證據）等級。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.23
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
U · 主流反證據
信心度
80%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.233
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative)，由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Oral evening primrose oil and borage oil for eczema (Cochrane Systematic Review)
結論：Across 19 RCTs (7 EPO trials with 176 participants assessed for global severity; 8 borage oil trials) oral EPO and borage oil produced NO clinically meaningful effect on eczema vs placebo (participant-assessed global eczema symptoms SMD -0.02, 95% CI -0.24 to 0.20; investigator-assessed SMD 0.00); the authors concluded oral EPO and borage oil are not effective for eczema and further studies were unlikely to change this conclusion.
前往 PubMed
Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial
結論：Over 12 weeks borage oil produced no statistically significant improvement over placebo in the SASSAD total symptom score (treatment effect 1.4, 95% CI -2.2 to 5.0) in adults nor children with atopic eczema; topical steroid potency requirements did not differ.
前往 PubMed
Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results
結論：After 16 weeks of treatment EPO showed no statistically significant clinical benefit over placebo for chronic hand dermatitis; both groups improved equivalently, consistent with the broader EPO atopic-dermatitis literature.
前往 PubMed
Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study
結論：After 4 weeks, mild-to-moderate atopic dermatitis patients receiving 320 mg/day EPO showed a small reduction in EASI vs placebo (EASI mean change -1.5 vs -0.5, p<0.05), but the absolute clinical magnitude was modest, the dose was low, and follow-up was short.
前往 PubMed
Diet and eczema: a review of dietary supplements for the treatment of atopic dermatitis
結論：Pooled across heterogeneous trials EPO did not show a statistically robust improvement in SCORAD vs placebo; the authors note marked heterogeneity, small studies, industry sponsorship and publication bias, and that the Cochrane review's negative conclusion remains the most defensible synthesis.
前往 PubMed
L4a US FDA
謹慎
In 1985, FDA issued a series of Import Alerts announcing that Evening Primrose Oil could not be sold lawfully in the United States without FDA approval, that the substance did not have FDA approval, and that all import shipment of evening primrose oil offered for entry into the U.S. were to be detained by Customs. 來源↗
L4b EU EFSA
反對
L4c UK NHS
反對
[NHS.uk, menopause herbal remedies page] Evening primrose oil is listed among herbal remedies "sometimes taken for menopause symptoms"; the page warns that such herbal remedies "are not tested and regulated in the same way as medicines such as hormone replacement therapy (HRT), so it's not known how safe and effective they are", may "cause unpleasant side effects", and that "the quality, purity… 來源↗
L4d TW TFDA / 衛福部
中性
在台灣食品法規下，月見草油不得標示療效，也不得聲稱療效。除健康食品外，一般食品均不得宣稱保健功效。 來源↗
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
謹慎
There's not enough evidence to support the use of evening primrose oil for any health condition. ... Evening primrose oil, taken orally, has not been shown to be helpful for relieving symptoms of atopic dermatitis. ... Evening primrose oil is probably not more effective than a placebo (an inactive substance) for breast pain. ... There's insufficient evidence to show whether evening primrose oil… 來源↗
L5b Mayo Clinic
謹慎
Most research on the use of evening primrose offers little to no help for atopic dermatitis, also called eczema. Evening primrose oil is likely safe for most people to take for a short time, but research hasn't found that the supplement treats any condition. 來源↗
L5c Cleveland Clinic
反對
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
反對
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
社群討論偏向經前症候群與女性保養，純皮膚題反應分歧：少數鄉民實測口服月見草油急救濕疹效果「超明顯」，但多被引述的皮膚科醫師與 Cochrane 回顧則指對異位性皮膚炎、濕疹、乾癬普遍無顯著效果。品牌討論被大量保健品業配文蓋過，乾淨的真實使用心得相對稀少。
💬社群實感
分歧（少數口服急救濕疹回報效果明顯，但多數引述醫師/文獻認為對異位性皮膚炎、濕疹無顯著效果）
破解迷思 社群最常見的 4 個誤解
✓
事實以為塗抹患部就能吸收（鄉民與衛教指出應塗在健康皮膚才吸收，塗患部反而適得其反）
✓
事實期待立竿見影（GLA 補充需長期數月才見效，非短期見效）
✓
事實誤以為一般飲食中的 Omega-6 就足夠（現代加工油脂無法替代 GLA）
✓
事實把『改善皮膚保濕/搔癢』誤當成『可治療異位性皮膚炎』（證據並不支持）
🩹 社群通報的副作用
- 出血/瘀青風險（與抗凝血劑併用）
- 癲癇患者可能提高發作風險
- 開封後油易氧化耗味（影響服用意願）
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- BHK's
- 大研生醫 Daiken
- 普瑞登 Puritan
- 琉璃苣油（常被當作高 GLA 替代品討論）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 每日防曬（廣效、SPF 30 以上）
- 規律保濕與溫和清潔
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-skin-health-INT-evening-primrose-oil-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "月見草油能改善皮膚健康",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"alternateName": "證據不足 (Insufficient evidence)"
}
}